Head & Neck/Thyroid Cancers
From the Journals
Many Patients With Cancer Visit EDs Before Diagnosis
Factors associated with an increased likelihood of an ED visit ahead of diagnosis included having certain cancers, living in rural areas, and...
From the Journals
Plasma Omega-6 and Omega-3 Fatty Acids Inversely Associated With Cancer
The findings support possible small net protective roles of omega-3 and omega-6 PUFAs in the development of new cancer incidence, the researchers...
Conference Coverage
ATA: Updates on Risk, Diagnosis, and Treatment of Thyroid Cancer
Researchers compared medical records of adults with type 2 diabetes and moderate cardiovascular risk who were new users of GLP-1 receptor agonists...
From the Journals
Thyroid Cancer Overdiagnosis Continues Despite Cautions
More than 1.7 million people might have been overdiagnosed between 2013 and 2017 in 63 countries, estimated the authors of a new paper.
Feature
For Radiation ‘Downwinders,’ Cancer Compensation Is On Hold
A federal program to compensate patients whose exposure to radiation caused cancer has expired, but screenings and efforts to revive and expand...
Feature
Cannabis in Cancer: What Oncologists and Patients Should Know
Access to and use of cannabis alongside cancer care have outpaced the science on evidence-based indications, according to an ASCO expert panel.
From the Journals
Risk Assessment Tool Can Help Predict Fractures in Cancer
Researchers collected data on bone mineral density and fractures in 9,877 patients with cancer and 45,875 matched control individuals without...
Latest News
One-Dose HPV Vaccine Program Would Be Efficient in Canada
The model projected that a noninferior one-dose, gender-neutral HPV vaccination program would avert a similar number of cervical cancer cases,...
Latest News
Time to Stop Saying Thyroid Cancer Is a ‘Good’ Cancer
Although papillary thyroid cancer outcomes generally are good, the disease can still be life-altering for years to come.
Feature
Popular Weight Loss Drugs Now for Patients With Cancer?
Research suggests that obesity can reduce the effectiveness of cancer therapies.
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...